(Circulation. 2001;103:626.)
© 2001 American Heart Association, Inc.
Editorials |
From Winters Center for Heart Failure Research; the Cardiology Section, Department of Medicine, Baylor College of Medicine; and the Houston Veterans Administration Medical Center, Houston Texas.
Correspondence to Douglas L. Mann, MD, Cardiology Research (151C), VA Medical Center, 2002 Holcombe Blvd, Houston, TX 77030. E-mail dmann@bcm.tmc.edu
Key Words: Editorials tumor necrosis factor myocarditis cytokines inflammation
"In this world there are only two tragedies. One is not getting what one wants, and the other is getting it."Oscar Wilde
Tumor necrosis factor (TNF) has been referred to a "mixed blessing for higher organisms."1 That is to say, although the controlled self-limited expression of TNF plays a critical role in activating host defense mechanisms and in homeostatic tissue repair, uncontrolled overexpression of TNF produces devastating consequences for the host organism, frequently leading to diffuse inflammation, multiorgan dysfunction, hemodynamic collapse, and death. Although a similar "bifunctional picture" for TNF has not yet emerged clearly for the heart, the report by Wada and colleagues2 in the present issue of Circulation suggests that TNF may be a mixed blessing for the heart as well.
Several lines of evidence suggest that proinflammatory
cytokines, such as TNF, play an important role in the pathogenesis of
viral myocarditis. For example, elevated levels of TNF have been
reported in patients with viral
myocarditis.3 Importantly,
TNF mRNA and protein are consistently upregulated in the hearts of
patients with viral
myocarditis.4 Mice with
targeted overexpression of TNF in the cardiac compartment develop
florid myocarditis and progressive myocardial
fibrosis.5 6 The
exogenous administration of TNF aggravates myocarditis, and the
neutralization of TNF by antibodies or soluble receptors attenuates
viral
myocarditis.7 8
Taken together, these observations suggest that TNF plays an important
pathophysiological role in the development and progression of viral
myocarditis. In the present issue of
Circulation, Wada and
colleagues2 report that mice
with targeted disruption of the TNF
This article has been cited by other articles:
![]() |
J. A. Carroll Bidirectional communication: Growth and immunity in domestic livestock J Anim Sci, April 1, 2008; 86(14_suppl): E126 - E137. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Guilherme, P. Cury, L. M.F. Demarchi, V. Coelho, L. Abel, A. P. Lopez, S. E. Oshiro, S. Aliotti, E. Cunha-Neto, P. M.A. Pomerantzeff, et al. Rheumatic Heart Disease: Proinflammatory Cytokines Play a Role in the Progression and Maintenance of Valvular Lesions Am. J. Pathol., November 1, 2004; 165(5): 1583 - 1591. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Peng, X. Lu, M. Lei, and Q. Feng Endothelial Nitric-oxide Synthase Enhances Lipopolysaccharide-stimulated Tumor Necrosis Factor-alpha Expression via cAMP-mediated p38 MAPK Pathway in Cardiomyocytes J. Biol. Chem., February 28, 2003; 278(10): 8099 - 8105. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Martire, B. Fernandez, A. Buehler, C. Strohm, J. Schaper, R. Zimmermann, P. E Kolattukudy, and W. Schaper Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice mimics ischemic preconditioning through SAPK/JNK1/2 activation Cardiovasc Res, February 1, 2003; 57(2): 523 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sun, J. Zhang, L. Lu, S. S. Chen, M. T. Quinn, and K. T. Weber Aldosterone-Induced Inflammation in the Rat Heart : Role of Oxidative Stress Am. J. Pathol., November 1, 2002; 161(5): 1773 - 1781. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M Smith, S. Lecour, and M. N Sack Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program Cardiovasc Res, August 15, 2002; 55(3): 474 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M Smith, N. Suleman, J. McCarthy, and M. N Sack Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNF{alpha} gene Cardiovasc Res, August 15, 2002; 55(3): 553 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. de' Clari, I. Salani, E. Safwan, and A. Giannacco Sudden Death in a Patient Without Heart Failure After a Single Infusion of 200 mg Infliximab: Does TNF-{alpha} Have Protective Effects on the Failing Heart, or Does Infliximab Have Direct Harmful Cardiovascular Effects? Circulation, May 28, 2002; 105 (21): e183 - e183. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |